_(3).png)
_(4).png){kind=logo}
Loading Shopping Cart Items...
FREE FOR MEMBERS!
Description: The session briefly covers the clinical relevance of current pathologic classifications in lymphoma. Choice and performance of ancillary laboratory testing platforms and results, with a focus on diagnostic yield.
Date: December 7, 2022
Time: 12pm – 1pm (ET)
At the end of this session you will understand the:
Speaker: Vishala Neppalli, MD
Dr. Neppalli is a hematopathologist with an advanced expertise in lymphoid disorders. She is a US trained specialist, and practiced as an academic pathologist at University of Iowa Hospitals and Clinics, and at Roswell Park Comprehensive Cancer Centre (RPCCC, Buffalo, NY), prior to moving to Winnipeg. At RPCCC, Dr. Neppalli was the Chief of Division of Diagnostic Hematology, where she was instrumental in developing an integrated hematopathology diagnostic reporting model. She has served as a panel member on Myeloma, Chronic lymphocytic leukemia/Hairy cell leukemia/Waldenstrom macroglobulinemia National Comprehensive Cancer Network (NCCN) guidelines. She moved back to her hometown Buffalo, NY in July 2022, and joined Eastern Great Lakes Pathology and X-Cell Laboratories of Western New York, providing hematopathology diagnostic support to Western New York.
PEP hours: 1.0
CPS credits: 0
*Note: PEP hours and/or CPS credits will only be awarded upon successful completion of the quiz.
Loading Shopping Cart Items...